文献速递关节外科

钴铬头在年轻人群中表现劣于陶瓷头和陶瓷化金属头:美国关节置换登记报告

Cobalt Chrome Heads Underperform Ceramic and Ceramicized Metal Heads in the Younger Population: An American Joint Replacement Registry Report.
PubMed 文献 · J Arthroplasty · 2025-09-10

基于美国关节置换登记系统2012年1月至2022年6月的数据,纳入18至54岁首次全髋关节置换术且随访至少1年的101313例患者,比较六种现代摩擦界面的翻修率。陶瓷化金属对交联聚乙烯的全因翻修率最低(1.95%,n=197),且陶瓷化金属、陶瓷对交联聚乙烯和陶瓷对抗氧化聚乙烯均优于金属对交联聚乙烯;陶瓷对陶瓷的无菌性松动翻修率最低。作者认为在现代摩擦界面中,陶瓷或陶瓷化金属对聚乙烯界面应被视为该人群的金标准。

要点

  • 在18至54岁首次全髋关节置换人群中,现代摩擦界面的全因翻修率低,生存率超过96%。
  • 陶瓷化金属对交联聚乙烯的全因翻修率为1.95%(n=197),低于金属对交联聚乙烯(HR=0.72,95%CI 0.59至0.87,P<0.001)。
  • 陶瓷对陶瓷的无菌性松动翻修率最低(P<0.001),陶瓷对抗氧化聚乙烯(HR=0.41)、陶瓷化金属对交联聚乙烯(HR=0.42)和陶瓷对交联聚乙烯(HR=0.55)均优于金属对交联聚乙烯。

核心结论

  • 在年轻人群中,现代摩擦界面的全因翻修率低,但头材质仍是生存率的重要驱动因素。
  • 作者认为,在该患者人群中,陶瓷或陶瓷化金属对聚乙烯界面应被视为金标准。

研究设计与样本

  • 分析美国关节置换登记系统2012年1月至2022年6月的数据,纳入年龄18至54岁、接受首次全髋关节置换术、随访至少1年且使用六种摩擦界面之一的患者。
  • 六种摩擦界面为:陶瓷对陶瓷、陶瓷对交联聚乙烯、陶瓷对抗氧化聚乙烯、陶瓷化金属对交联聚乙烯、钴铬对交联聚乙烯(即金属对聚乙烯)和金属对抗氧化聚乙烯。
  • 采用方差分析、卡方检验和Fisher精确检验评估结局,并构建Cox比例风险模型,以风险比(HR)和置信区间(CI)报告。

主要发现

  • 共识别101313例首次全髋关节置换术病例,大多数患者接受陶瓷对交联聚乙烯界面(64.2%),生存率超过96%。
  • 陶瓷化金属对交联聚乙烯的全因翻修率最低(1.95%,n=197),且全因翻修可能性低于金属对交联聚乙烯(HR=0.72,95%CI 0.59至0.87,P<0.001)。
  • 陶瓷对交联聚乙烯(HR=0.73,95%CI 0.64至0.84,P<0.001)和陶瓷对抗氧化聚乙烯(HR=0.77,95%CI 0.64至0.94,P=0.003)的全因翻修表现均优于金属对交联聚乙烯。
  • 陶瓷对陶瓷的无菌性松动翻修率最低(P<0.001);陶瓷对抗氧化聚乙烯(HR=0.41,95%CI 0.27至0.64,P<0.001)、陶瓷化金属对交联聚乙烯(HR=0.42,95%CI 0.56至0.70,P<0.001)和陶瓷对交联聚乙烯(HR=0.55,95%CI 0.41至0.74,P<0.001)的无菌性松动翻修表现均优于金属对交联聚乙烯。

关键数值与推荐

  • 陶瓷化金属对交联聚乙烯相比金属对交联聚乙烯的全因翻修HR=0.72(95%CI 0.59至0.87,P<0.001)。
  • 陶瓷对交联聚乙烯相比金属对交联聚乙烯的全因翻修HR=0.73(95%CI 0.64至0.84,P<0.001)。
  • 陶瓷对抗氧化聚乙烯相比金属对交联聚乙烯的全因翻修HR=0.77(95%CI 0.64至0.94,P=0.003)。
  • 陶瓷对抗氧化聚乙烯相比金属对交联聚乙烯的无菌性松动翻修HR=0.41(95%CI 0.27至0.64,P<0.001)。
  • 陶瓷化金属对交联聚乙烯相比金属对交联聚乙烯的无菌性松动翻修HR=0.42(95%CI 0.56至0.70,P<0.001);陶瓷对交联聚乙烯相比金属对交联聚乙烯的无菌性松动翻修HR=0.55(95%CI 0.41至0.74,P<0.001)。

临床怎么用

  • 作者认为,在年轻患者人群中,陶瓷或陶瓷化金属对聚乙烯界面应被视为金标准。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of fourth-generation ceramic, ceramicized metal, and antioxidant polyethylene has not been well characterized in younger patients undergoing total hip arthroplasty (THA). This study aimed to compare the revision rates of modern bearing couples in this population. METHODS: American Joint Replacement Registry data was analyzed between January 2012 and June 2022 for patients aged 18 to 54 years who underwent a primary THA, had at least 1-year follow-up, and received one of six bearing types (ceramic on ceramic [CoC], ceramic on cross-linked polyethylene [CoP], ceramic on antioxidant polyethylene [CoAOP], ceramicized metal on cross-linked polyethylene [CMoP], cobalt chromium on CoP ["metal on polyethylene," MoP], and metal on antioxidant polyethylene). Outcomes were assessed through analysis of variance, chi-square, and Fisher exact tests. Cox proportional hazard models were conducted and reported as hazard ratios (HRs) and confidence intervals (CIs). RESULTS: A total of 101,313 primary THA cases were identified; most patients received a CoP bearing (64.2%), and survivorship exceeded 96%. Also, CMoP had the lowest rate and a lower likelihood of all-cause revision compared to MoP (1.95%, n = 197; HR = 0.72; CIs: 0.59 to 0.87; P < 0.001). In addition to CMoP, CoP (HR = 0.73; CIs: 0.64 to 0.84; P < 0.001) and CoAOP (HR = 0.77; CIs: 0.64 to 0.94; P = 0.003) outperformed MoP. The lowest rate of revision for aseptic loosening was seen with CoC (P < 0.001), with CoAOP (HR = 0.41; CIs: 0.27 to 0.64; P < 0.001), CMoP (HR = 0.42; CIs: 0.56 to 0.70; P < 0.001), and CoP (HR = 0.55; CIs: 0.41 to 0.74; P < 0.001) also outperforming MoP. CONCLUSIONS: All-cause revision rates in this younger population are low with modern bearings. Head composition remains an important driver of survivorship. Ceramic or ceramicized metal on a polyethylene bearing should be considered the gold standard in this patient population.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Reddy AR, Miley EN, Jahan M, et al. Cobalt Chrome Heads Underperform Ceramic and Ceramicized Metal Heads in the Younger Population: An American Joint Replacement Registry Report. J Arthroplasty. 2025. PMID: 40939940. doi:10.1016/j.arth.2025.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。